跳至主要内容
临床试验/NL-OMON54947
NL-OMON54947招募中不适用

Quantifying disease progression in LBSL - Disease progression in LBS

Academisch Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • - Age > 16 years
  • - Definite diagnosis of LBSL confirmed by DARS2 mutation analysis.
  • - Able to understand Dutch or English and provide informed consent.
  • - No contra-indications for MRI of brain and spinal cord.
  • Subjects eligible to participate as healthy controls must meet all of the
  • following criteria:
  • - Willing to visit the hospital
  • - 16 years or older
  • - Provision of written informed consent to participate in the study obtained
  • from the participant
  • For the MRI controls
  • - No contra-indications for MRI of brain and spinal cord.

排除标准

  • Pediatric patients
  • Unable to provide informed conset

研究者

相似试验

Quantifying disease progression in LBS | 临床试验